Shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Free Report) are going to reverse split on the morning of Thursday, July 18th. The 1-10 reverse split was announced on Thursday, July 18th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, July 18th.
Senti Biosciences Stock Performance
Shares of SNTI stock remained flat at $0.31 during trading hours on Tuesday. The stock had a trading volume of 689,989 shares, compared to its average volume of 3,465,145. Senti Biosciences has a 1 year low of $0.21 and a 1 year high of $1.09. The business has a 50 day simple moving average of $0.32 and a 200-day simple moving average of $0.38.
Senti Biosciences (NASDAQ:SNTI – Get Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.26) earnings per share (EPS) for the quarter. As a group, research analysts predict that Senti Biosciences will post -1 EPS for the current fiscal year.
Hedge Funds Weigh In On Senti Biosciences
Senti Biosciences Company Profile
Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.
Featured Articles
- Five stocks we like better than Senti Biosciences
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Tech Leader’s Stock Split: Is It the Right Time to Buy?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Could the Economy be Bottoming? Major Bank’s Earnings Say Yes
- How to Most Effectively Use the MarketBeat Earnings Screener
- Seize This Prime Stock Opportunity on Amazon Prime Days
Receive News & Ratings for Senti Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senti Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.